HCA Healthcare, Inc.

The filings on file give a clear picture of scale and a mixed picture of risk. At December 31, 2025, HCA operated 190 hospitals (179 general acute care, seven behavioral, four rehabilitation), 121 freestanding ambulatory surgery centers and 31 freestanding endoscopy centers across 19 states and England, with 50,436 licensed beds at the general acute care hospitals. Revenue grew to $75.6 billion in 2025 from $51.34 billion in 2019, and net income moved from $3.5 billion in 2019 to $6.78 billion in 2025. Net income as a share of revenue was about 9.0% in 2025 versus about 8.2% in 2024, a simple ratio of the reported figures. The 10-Q's controls section reports disclosure controls effective as of March 31, 2026, and no changes in internal control over financial reporting. Legal matters are incorporated by reference to Note 8 (Contingencies), which is not in the excerpt, and Exhibit 22 lists subsidiary guarantors and pledged securities; readers may want to look at both to understand the debt structure. Forensic scores: none are on file for this synthesis, so no Beneish, Piotroski or Altman reading is given here. Readers may want to look at the risk-factor sections on staffing, the new electronic health record platform, and cybersecurity, which the summary identifies as ongoing operational exposures. Overall, the reported figures show growth in revenue and profit, but whether that holds depends on whether the debt and labor pressures named in the risk factors persist, which these excerpts cannot establish.

Catalyst.Per the annual figures on file, revenues rose from $70.6 billion in 2024 to $75.6 billion in 2025, about 7.1% growth, and net income rose from $5.76 billion to $6.78 billion, about 17.7%. Item 1 of the 10-K ties this to a growth agenda: growing presence in existing markets, recruiting physicians, and advancing digital and artificial intelligence capabilities, with 190 hospitals and 121 freestanding ambulatory surgery centers at December 31, 2025. The 10-Q's MD&A excerpt provided does not include the operating discussion, so the drivers behind these results cannot be confirmed from it.

Hidden risk.The 10-K risk factors summarized in Item 1 lead with indebtedness: HCA has significant debt, may take on more, has variable rate debt exposed to interest rate changes, and its debt agreements restrict operating flexibility. The 10-Q states there were no material changes to risk factors and incorporates the 10-K by reference, so a reader must go to that 10-K for the full text. Capital return is also large relative to what the excerpts show: Q1 2026 repurchases of 3,156,569 shares at an average $497.63 come to roughly $1.57 billion, and $9.179 billion remains under the January 2026 authorization. The cash flow statement is not in the excerpts, so the funding source cannot be checked.